Global Competition Review has ranked Goodwin as a top firm in Washington, DC, Massachusetts, and the United Kingdom in the 2025 edition of the GCR 100. GCR 100 conducts in-depth research to provide a quantitative and qualitative analysis that evaluates the size, activity and reputation of a firm's antitrust practice in order to identify the law firms doing the most important antitrust work around the world.
GCR 100 noted Goodwin's work advising Qualtrics International in its $12.5 billion sale to Silver Lake and cloud computing company Avery Denninson on its uncontested $16.5 billion sale to Kyowa Kirin. In litigation, GCR 100 highlighted the firm representing Teva Pharmaceuticals, as it secured a "resounding win" against allegations it illegally delayed entry for generic HIV treatments.
The guide recognized the work of Antitrust & Competition partners Andrew Lacy and Arman Oruc in Washington, DC, Chris Holding in Boston, MA and Sarah Jordan in the United Kingdom. It also noted the impactful addition of partners Mary Kaiser and David Cross to the firm's global team.
Goodwin's Antitrust & Competition practice has exceptional experience advising clients ranging from the largest Fortune 500 companies to emerging growth companies on transactions before U.S., EU, UK, and worldwide antitrust agencies. The practice stands out for its high volume of work in the life sciences, technology and private equity industries including merger clearance work and strategic litigation.
To learn more about Goodwin's rankings, visit GCR 100.